• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
      • Cardiac Safety IconCardiac Solutions
        • Cardiac Solutions

          Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Arrhythmia Analysis

          Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Blood Pressure Services

          Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • ECG — On-site to DCT and Phase I-IV

          Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Phase I/TQT Cardiac Assessment

          Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Regulatory Consultation and Statistical Analysis Expertise

          Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

      • Clinical Adjudication
      • ECOA IconeCOA
        • eCOA Clinical Trials

          Make your clinical trials easier, faster, more engaging and accessible to all.

        • eCOA Live

          Enjoy flexible, fast and confidential site assessments at home.

        • eCOA Multimedia

          Enhance your ePRO data with photo and audio capture.

        • eCOA Rapid Start

          Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • eCOA Rater and Participant Training

          Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • eCOA Rescue Studies

          Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Suicidal Ideation

          Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

      • Medical ImagingMedical Imaging
        • Medical Imaging

          Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • Medical Imaging science team

          The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Image Redact AI

          Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Imaging Platform

          Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Modalities

          Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • SMART Submit

          Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

      • Precision Motion IconPrecision Motion
        • Precision Motion for Clinical Trials

          Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • Precision Motion for Research

          The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Precision Motion: Scientific Publications

          Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

      • Respiratory Solutions IconRespiratory
        • Respiratory Solutions

          Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Site-Based Spirometry (FEV1, FVC, PEF, and more.)

          Centralized, on-site pulmonary function testing for clinical trials.

        • Virtual Home Spirometry

          Remote spirometry testing for respiratory clinical trials.

        • Cough and Lung Sounds

          Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Diffusing Capacity (DLCO)

          Assess the capacity of the lungs for effective gas transfer.

      • Trial Enablement IconTrial Enablement
        • Trial Enablement

          Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Eligibility Solution

          Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Reporting & Analytics

          Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Source Document Manager

          Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
      • Biotechs
      • CROs
      • Pharmacist Icon RGBPharma
    • Study Phases
      • Safety Icon RGBPhase I
      • Clinical Trial Management System Icon RGBPhase II/III
    • Technology
      • AI Icon RGBArtificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Hybrid Trials
    • Biotechs
    • CROs
    • Pharma
    • Phase I
    • Phase II/III
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Type 2 Diabetes and Obesity
    • Respiratory Solutions
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Blog Articles The Heart of the Matter

The Heart of the Matter

Sudden Cardiac Arrest in Young Athletes and Those Working to Prevent It

Todd Rudo, M.D. – Chief Medical Officer at Clario

LeBron James is widely regarded as one of the greatest professional basketball players in the sport’s history. This summer, his 18-year-old son Bronny James suffered a cardiac arrest during a college basketball team practice and was quickly resuscitated and rushed to the hospital. Fortunately, the news from there has all been positive. He was released back home after several days and reportedly has recovered quite well. Although details are limited, it was recently revealed that he was diagnosed with a congenital heart defect. 

But what actually happened, and what can be done to prevent this? 

I write this blog now not just to share some background on sudden cardiac arrest in athletes but also because I want to highlight Clario’s involvement with Simon’s Heart, an organization dedicated to preventing sudden cardiac arrest in children and young adults. One of the core initiatives of Simon’s Heart is providing free heart screenings to students in an effort to detect cardiac abnormalities and prevent tragedy. 

Clario has donated decommissioned ECG machines to Simon’s Heart for nearly ten years to enable these screenings.  The organization has screened the hearts of almost 20,000 students since its inception, with more than 10,000 of those on Clario machines. Through these efforts, they have been able to diagnose previously undetected heart conditions in almost 150 students! 

Back to Bronny James though – how common is this? Every year, about 2,000 people in the United States under the age of 25 die from sudden cardiac arrest. For context, car accidents kill about 11,000 each year in this same age group. The frequency of sudden cardiac death may not be very high, but the consequences are devastating, especially considering that in most cases, those deaths were preventable.

The most common cause of sudden cardiac arrest in young athletes is a condition called hypertrophic cardiomyopathy (HCM). HCM, which is an inherited genetic disease, is a result of the heart muscle growing excessively thick with disorganized muscle cells, causing it to function inappropriately. In some cases, the first symptom of HCM is a lethal heart rhythm, called ventricular tachycardia (VT). Without interventions such as CPR, life-saving medications, and a defibrillator shock, VT is a fatal rhythm. Screening with history and physical exam, ECG, and if appropriate an echocardiogram, can aid in detecting this condition. There are many other types of inherited, structural heart abnormalities that can also lead to VT and sudden death, but HCM is the most common. 

A slightly less common cause of cardiac arrest in athletes is myocarditis. In this condition, the heart muscle becomes inflamed, usually following a viral infection, but sometimes can result from an underlying immune system disorder. Famously, college basketball player Hank Gathers, Loyola Marymount University’s leading scorer and a candidate for the player of the year in the 1988-1989 season, suffered sudden cardiac arrest and died, his autopsy revealing evidence for myocarditis. Similar to HCM, often the symptoms of this are either absent, very limited, or quite vague, but with ECG, blood work, and imaging tests, it is generally detectable and manageable.

And of course, many of us remember the recent collapse of professional football player Damar Hamlin last season, an apparent case of commotio cordis. This is an exceptionally rare condition in which a blow to the chest can cause a sudden change in heart rhythm called ventricular fibrillation. With quick reaction on the field that day his life was saved, a tribute to the preparedness of the trainers and field medical staff, ready to respond urgently. 

Simon Sudman suffered from a different condition though. He was a seemingly healthy three-month-old baby boy who sadly died one night in his sleep. After his parents were encouraged by their pediatrician to get their own hearts checked, Phyllis, Simon’s mom, discovered a heart condition called Long QT Syndrome (LQTS). LQTS has been linked to up to 15% of sudden infant deaths (SIDS). Like the others, this is yet another condition that is largely without any symptoms, and only with proper screening can a diagnosis be made. Long QT syndrome can cause cardiac arrest at any age, not just in children. 

At Clario, most of the work our Cardiac Safety group focuses on is the detection of drug-induced QT prolongation. While some people have an inherited abnormality with the QT interval (as Simon did), certain medications can also directly cause the same condition to develop. If taken in high enough doses, those medications can also cause sudden death. Importantly, with proper screening during a clinical trial and high-quality ECG data, this is detectable and preventable. If a medicine is determined to prolong the QT interval, physicians can be warned of this risk and monitor patients more closely during treatment. 

Screening young children and athletes for cardiac disease is sometimes a controversial topic. There is an argument that the cost of ECG screening, and the risk of false positives leading to unnecessary additional testing, outweigh the benefits of screening for such rare conditions. Some argue that only children with risk factors (such as family history) or concerning symptoms (such as fainting episodes, exertional chest pain, and heart palpitations) require an ECG or echocardiogram. Founded by Simon’s parents, Darren and Phyllis Sudman, the vision of Simon’s Heart is a future in which parents and communities don’t lose children to detectable and treatable heart conditions. They pursue this vision through free heart screenings for students, placing AEDs where children learn and play, providing CPR Education, and through Advocacy. Until public policy changes and makes screening routine, Clario will continue to support this important cause, and do our part to make a difference. 

Advancing science, saving lives

The intricacies of sudden cardiac arrest in young individuals require rigorous research, understanding, and intervention. Learn more about the scientific efforts and evidence-based approaches adopted by Simon’s Heart.

Learn More
Back to articles
Share
Twitter Facebook LinkedIn

Latest articles

See all articles
Article

Researcher spotlight: Dr. Lauren Tueth

Precision Motion

Read
Article

Researcher spotlight: Brice Cleland

Precision Motion

Read
Article

Researcher spotlight: Josefa Domingos

Precision Motion

Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum